Health, Fitness & Food

In this article LLY Follow your favorite stocksCREATE FREE ACCOUNT Eli Lilly headquarters in Indianapolis, Indiana, US, on Wednesday, May 3, 2023. Eli Lilly & Co.’s shares climbed in early US trading after its experimental drug for Alzheimer’s slowed the progress of the disease in a final-stage trial, paving the way for the company to
0 Comments
In this article GSK-GB GSK Follow your favorite stocksCREATE FREE ACCOUNT A view shows GlaxoSmithKline headquarters in London, Britain, January 17, 2022. Hannah Mckay | Reuters The Food and Drug Administration on Friday expanded the approval of GSK‘s respiratory syncytial virus vaccine to adults ages 50 to 59 who are at increased risk of getting
0 Comments
Patient using Sword Health. Courtesy: Sword Health Pain management startup Sword Health on Tuesday announced a new artificial intelligence solution named Phoenix that patients can speak with for guidance through virtual physical therapy sessions.  Sword, founded in 2015, offers digital tools to help patients manage pain from home and avoid other treatments like opioids and
0 Comments
Company logo of pharmaceutical company GlaxoSmithKline is seen at their Stevenage facility, Britain October 26, 2020.  Matthew Childs | Reuters LONDON — Shares of British pharmaceuticals giant GSK plunged 9% Monday, after a U.S. court ruled that scientific evidence could be presented as a stack of lawsuits relating to the discontinued heartburn drug Zantac move forward.
0 Comments
In this article MRK MRNA Follow your favorite stocksCREATE FREE ACCOUNT Artur Widak | Nurphoto | Getty Images Moderna and Merck released more positive three-year data Monday on their experimental vaccine, given to patients with the most deadly form of skin cancer in combination with the therapy Keytruda. The vaccine together with Merck’s Keytruda improved
0 Comments
In this article NES.N-CH Follow your favorite stocksCREATE FREE ACCOUNT The meteoric rise of weight loss drugs means consumers’ nutritional needs are “shifting” which provides new opportunities for food companies, Nestle CEO Mark Schneider told CNBC. Investors were initially concerned about the popularity of GLP-1 drugs such as Wegovy and Ozempic as it was assumed
0 Comments
In this article OR-FR Follow your favorite stocksCREATE FREE ACCOUNT L’Oreal says it is working with start-ups and research institutions to bioprint skin that can actually “feel.” L’Oreal PARIS, France — French beauty and cosmetics giant L’Oreal is working on a form of synthetically produced skin that it says will one day be able to
0 Comments